Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB03 Agalsidase alfa
D02784 Agalsidase alfa (USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
395 Enzyme preparations
3959 Others
D02784 Agalsidase alfa (USAN/INN); Agalsidase alfa (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GLA* [HSA_VAR:2717v1]
D02784 Agalsidase alfa (USAN/INN) <JP>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02784
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02784
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D02784
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB04 Agalsidase beta
D03228 Agalsidase beta (INN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Agalsidase Beta
D03228 Agalsidase beta (INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
395 Enzyme preparations
3959 Others
D03228 Agalsidase beta (INN); Agalsidase beta (genetical recombination) (JAN); Agalsidase beta (genetical recombination) [Agalsidase beta biosimilar 1] (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GLA* [HSA_VAR:2717v1]
D03228 Agalsidase beta (INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03228
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03228
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D03228
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB20 Pegunigalsidase alfa
D11685 Pegunigalsidase alfa (USAN/INN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Pegunigalsidase Alfa
D11685 Pegunigalsidase alfa (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GLA* [HSA_VAR:2717v1]
D11685 Pegunigalsidase alfa (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11685
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11685
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11685
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D11685